London pre-open: Triple digit rise for Footsie expected
27th Oct 2011 07:20
The market is set to give the thumbs-up to the measures announced by European leaders last night, which included bumping up the region's bail-out fund to €1trn and an agreement with Greek bond-holders that they should take a 50% 'haircut' on the value of the bonds. The response to the announcement
Read moreThursday preview: Shell, Astra, Bloomsbury
26th Oct 2011 15:49
Results from Royal Dutch Shell will, as usual, be compared to those from BP. Charles Stanley's Tony Shepard thinks the comparison will be favourable. "Shell could report a 29% rise in Q3 [third quarter] earnings to $6.3bn which, on the face of it, will be more positive than other groups such as BP
Read moreUPDATE: First broker tip round-up of the morning
30th Sep 2011 08:48
Intertek: UBS downgrades to ´sell´ from ´neutral´, cuts target to 1750p from 2000p. Tate&Lyle: UBS keeps at ´neutral´, raises target to 615p from 595p. Carphone: Alpha Value upgrades to 'add' from 'reduce'. IMI: Alpha Value upgrades to 'buy' from 'add'. Astra Zenaca: Seymour Pierce stays at 'r
Read moreLondon open: AstraZeneca the sole FTSE 100 riser
30th Sep 2011 08:26
Stocks have continued their downward turn amid ongoing uncertainty over the Eurozone situation. Data showing consumer confidence has risen for the first time in four months has failed to lighten the mood. The index of sentiment remained firmly negative in September at -30, up a point from the pre
Read moreAstra settles Seroquel dispute with Handa
30th Sep 2011 08:02
Drugs giant AstraZeneca has come to an accommodation with generic drugs rival Handa Pharmaceuticals over their legal dispute regarding Astra's Seroquel XR drug. The agreement settles the patent infringement litigation filed by AstraZeneca following Handa's submission to the US Food and Drug Adminis
Read moreLondon pre-open: Modest falls expected
30th Sep 2011 07:55
There is little sign of London pulling out of its slide, with City sources predicting the FTSE 100 will open down 38 points from yesterday's close of 5,197. Drugs giant AstraZeneca has entered into a settlement agreement in its US SEROQUEL XR patent infringement litigation against Handa Pharmaceuti
Read moreLondon close: Footsie tumbles over 2%
2nd Sep 2011 16:30
The Footsie finished over 2% down on Friday, as London was not immune from the global sell-off, meaning that just eight out of the 100 blue chips stocks closed in the blue. After a poor start in early trade, sentiment was dampened after a worse-than-expected jobs report in the US which showed that n
Read moreLondon midday: Stocks stuck lower ahead of jobs data
2nd Sep 2011 12:27
London's leading share index is firmly in the red now, giving up gains from earlier this week ahead of the big US jobs report due this afternoon. The eagerly awaited headline results from a clinical trial comparing AstraZeneca's cholesterol treatment Crestor to Pfizer's Lipitor have been released,
Read moreLondon open: Stocks give up gains ahead of US jobs report
2nd Sep 2011 08:26
Stocks have given up some of their recent gains amid nervousness ahead of this afternoon's big US jobs report. Among the fallers is drugs behemoth AstraZeneca, which has announced generally favourable results of tests of its cholesterol treatment, CRESTOR, though not the knock-out blow versus LIPIT
Read moreAstra's Crestor fails to outshine Lipitor
2nd Sep 2011 07:53
The eagerly awaited headline results from a clinical trial comparing AstraZeneca's cholesterol treatment Crestor to Pfizer's Lipitor have been released, and have not delivered the knock-out blow that the company was hoping for. The results for the primary efficacy measure of the study demonstrated
Read moreLondon pre-open: Heavy falls anticipated
2nd Sep 2011 07:18
Taking their lead from Wall Street, which closed lower ahead of today's August jobs data, London' leading shares are set to open well in the red, with City traders predicting the Footsie will open 82 points down from yesterday's close of 5,419. Drugs behemoth AstraZeneca has announced generally fav
Read moreComment: DMGT ponders Northcliffe options
1st Sep 2011 14:20
The closure of the Sunday tabloid the News of the World has given DMGT, publisher of the Mail on Sunday, a big boost. The consequent rise in revenues is likely to make a big difference to full-year profits at Associated Newspapers, DMGT's national newspaper division. Some had speculated that DMGT
Read moreLondon close: Stocks slide after US jobs disappointment
25th Aug 2011 16:39
After an uncertain start following a raft of mixed company updates, London's leading share index finished firmly in the red as some weak US jobs data set nerves on edge. Unemployment claims in the world's biggest economy unexpectedly rose by 5,000 to 417,000 in the week to 20 August. Traders are n
Read moreLondon midday: Mixed reception for deluge of updates
25th Aug 2011 12:10
London's leading share index is uncertain today as the continuing stream of company updates gets a mixed reception. Kazakhstan-focused copper miner Kazakhmys is in demand after it said underlying profits were 24% ahead in the first half and revealed details of a $250m buy-back programme. The group
Read moreLondon open: Company results drive FTSE 100 up 0.7%
25th Aug 2011 08:32
Some pleasing company results drove the Footsie higher in early trading while the banks were also providing a lift. Kazakhstan-focused copper miner Kazakhmys was a high riser after it said underlying profits were 24% ahead in the first half and revealed details of a $250m buy-back programme. The gr
Read more